388
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Comparison of half- and standard-dose ticagrelor in Chinese patients with NSTE-ACS

, , , , , , , , , , , , , , , , & show all
Pages 440-445 | Received 05 Aug 2015, Accepted 14 Dec 2015, Published online: 02 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Yue Wang, Beibei Liu, Leilei Chen, Yue Wang, Zhiqiang Wang, Xiaojiang Zhang, Min Suo, Gary S. Mintz & Xiaofan Wu. (2022) Safety and efficacy of low-dose ticagrelor in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention. Platelets 33:2, pages 304-311.
Read now
Piotr Adamski, Małgorzata Ostrowska, Eliano Pio Navarese & Jacek Kubica. (2021) Pharmacodynamic and clinical efficacy of reduced ticagrelor maintenance doses in patients with coronary artery disease. Current Medical Research and Opinion 37:2, pages 195-206.
Read now
Jing Shi, Meijiao He, Wennan Wang, Guangzhong Liu, Haiyu Zhang, Danghui Sun, Jianqiang Li, Hongyuan Mu, Minglu Xu, Chenyang Zhao, Jiayu Wang, Chongyang Zhang, Hai Cang, Shiqi Zhao, Zhiren Zhang & Yue Li. (2021) Efficacy and safety of different ticagrelor regimens versus clopidogrel in patients with coronary artery disease: a retrospective multicenter study (SUPERIOR). Platelets 32:1, pages 120-129.
Read now
Ziwei Xi, Fang Fang, Jiayang Wang, Jumana AlHelal, Yujie Zhou & Wei Liu. (2019) CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis. Platelets 30:2, pages 229-240.
Read now
Yun Jeong Lee, Hyewon Kim, Jiyeon Choi, Bo Hee Lee & Seok-Yong Lee. (2018) Evaluation of pharmacokinetic, pharmacodynamic, efficacy, and safety data of low-dose ticagrelor versus standard dose in East Asians: a systematic review. Therapeutics and Clinical Risk Management 14, pages 83-93.
Read now

Articles from other publishers (17)

Cui-cui Wang, Qing ZhaoBing-yan Guo, Jie Hao, Jia-jia Zhao, Jia-liang RenYa-qing SunXiao-rui ZhangXiu-ling YangJin-ming Liu. (2023) The Plasma Concentration of Ticagrelor and Aspirin as a Predictor of Bleeding Complications in Chinese Acute Coronary Syndrome Patients With Dual Antiplatelet Therapy: A Prospective Observational Study. Journal of Cardiovascular Pharmacology 82:2, pages 148-156.
Crossref
Yanan Pang, Minglu Ma, Jiachun Xia, Dong Wang, YanChen, Jianfei Ye, Zhongwei Jia, Sicheng Wu, Jian Yang & Lei Hou. (2022) A randomized non-inferiority study of low-dose and standard-dose ticagrelor after intervention for acute coronary syndrome: study protocol for the TIGER STUDY. Trials 23:1.
Crossref
Omar Kass-Hout, Joseph Stern, Ruth D Tangonan, Rami Z Morsi, Sonam Thind, Tareq Kass-Hout & Lee Guterman. (2022) An alternative reduced dose regimen of ticagrelor for neuroendovascular patients. Vascular, pages 170853812210928.
Crossref
Niklas Bergh, Anna Myredal, Per Nivedahl, Max Petzold, Sultan Zarin, Constanze Wartenberg & Susanna M. Wallerstedt. (2022) Efficacy and Safety of Clopidogrel Versus Ticagrelor as Part of Dual Antiplatelet Therapy in Acute Coronary Syndrome—A Systematic Review and Meta-analysis. Journal of Cardiovascular Pharmacology 79:5, pages 620-631.
Crossref
Wenqiang LiWei ZhuAnxin Wang, Guojun ZhangYisen ZhangKun WangYing ZhangChao WangLimin ZhangHui ZhaoPing WangKelin ChenJian Liu & Xinjian Yang. (2021) Effect of Adjusted Antiplatelet Therapy on Preventing Ischemic Events After Stenting for Intracranial Aneurysms. Stroke 52:12, pages 3815-3825.
Crossref
Woong Gil Choi, Gi Chang Kim, Cheol Ho Lee, Hye Young Kim & Dong Woon Kim. (2021) The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel. The Korean Journal of Internal Medicine 36:2, pages 352-361.
Crossref
Wenxi Dang, Jiajia Wang, Qing Zhang, Nairong Liu, Wenting Li & Zhuhua Yao. (2021) Analysis of individualized antiplatelet therapy for patients of acute coronary syndrome after percutaneous coronary intervention under the guidance of platelet function. Medicine 100:16, pages e25601.
Crossref
Yanbo Wang, Yunfa Jiang, Wei Zhi, Yang Fu, Qing Wang, Jianli Zhou, Shaochen Zheng & Guozhen Hao. (2020) Safety and feasibility of low‐dose ticagrelor in patients with ST ‐segment elevation myocardial infarction . Clinical Cardiology 44:1, pages 123-128.
Crossref
Na Zhang, Weisen Xu, Ou Li & Bing Zhang. (2020) The risk of dyspnea in patients treated with third-generation P2Y12 inhibitors compared with clopidogrel: a meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders 20:1.
Crossref
Qing Chen, Yuanyuan Zhang, Zhen Wang, Shuai Wang, Hao Zhang, Yiwen Wang, Chi Lu, Haochen Xuan, Chaofan Wang, Dongye Li & Tongda Xu. (2020) Efficacy and safety of low dose ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis. Postgraduate Medical Journal 96:1141, pages 693-702.
Crossref
Xue‐Jie Han, Jian‐Qiang Li, Zulfiia Khannanova & Yue Li. (2019) Optimal management of coronary artery disease in cancer patients. Chronic Diseases and Translational Medicine 5:4, pages 221-233.
Crossref
Guang Zhong Liu, Song Zhang, Dang Hui Sun, Jing Shi, Wan Lan Bo, Wen Nan Wang, Chong Yang Zhang, Zhong Hua Wang, Wei Feng, Mei Jiao He, Yuan Yuan Liu, Shuang Li, Lin Qun Zheng & Yue Li. (2019) Half-dose ticagrelor versus high-dose clopidogrel in reducing platelet reactivity in acute coronary syndrome patients with high on-clopidogrel platelet reactivity (divide study). European Journal of Clinical Pharmacology 75:8, pages 1059-1068.
Crossref
Chuan-Guo Guo, Lijia Chen, Esther W. Chan, Ka Shing Cheung, Takaaki Isshiki, Ian C. K. Wong & Wai K. Leung. (2019) Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y 12 inhibitors compared with clopidogrel . Alimentary Pharmacology & Therapeutics 49:1, pages 7-19.
Crossref
Naoki Misumida, Shunsuke Aoi, Sun Moon Kim, Khaled M. Ziada & Ahmed Abdel-Latif. (2018) Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: Systematic review and meta-analysis. Cardiovascular Revascularization Medicine 19:6, pages 689-694.
Crossref
Naoki Misumida, Gbolahan O. Ogunbayo, Sun Moon Kim, Odunayo Olorunfemi, Ayman Elbadawi, Richard J. Charnigo, Ahmed Abdel-Latif & Khaled M. Ziada. (2017) Higher Risk of Bleeding in Asians Presenting With ST-Segment Elevation Myocardial Infarction: Analysis of the National Inpatient Sample Database. Angiology 69:6, pages 548-554.
Crossref
Shuaibing Liu, Ling Xue, Xiangfen Shi, Zhiyong Sun, Zhenfeng Zhu, Xiaojian Zhang & Xin Tian. (2018) Population pharmacokinetics and pharmacodynamics of ticagrelor and AR-C124910XX in Chinese healthy male subjects. European Journal of Clinical Pharmacology 74:6, pages 745-754.
Crossref
Cai De Jin, Moo Hyun Kim, Junghee Bang & Victor Serebruany. (2017) A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study. Cardiology 138:4, pages 201-206.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.